Coronary CT Angiogram: How to Interpret Your Result

What a Coronary CT Angiogram Actually Measures

A CCTA measures the inside of your coronary arteries by injecting iodinated contrast and capturing images at specific moments in your cardiac cycle. The scanner resolves structures as small as 0.5 mm, allowing radiologists to see whether plaque is building inside the artery wall and whether that plaque is narrowing the channel through which blood flows.

The result is not a single number. It is a structured report covering four dimensions: plaque presence, stenosis severity, plaque composition, and vessel involvement. Each dimension matters for risk prediction and management.

Stenosis: The Percentage That Gets the Most Attention

Stenosis is the percentage of the artery lumen blocked by plaque. Radiologists grade it in bands rather than exact numbers, because CT resolution does not support millimeter-perfect precision in every patient.

| Stenosis band | What it means clinically | |---|---| | 0% | No identifiable plaque | | 1 to 24% | Minimal plaque, no flow limitation | | 25 to 49% | Mild plaque, no flow limitation | | 50 to 69% | Moderate, possibly flow-limiting | | 70 to 99% | Severe, likely flow-limiting | | 100% | Total occlusion |

A stenosis below 50% is classified as non-obstructive. The 2021 ACC/AHA Guideline on the Evaluation and Diagnosis of Chest Pain states that non-obstructive CAD still carries prognostic importance and should trigger lifestyle and medical therapy discussion rather than simple reassurance. [1]

Plaque Composition: Why "Type" Matters as Much as "Amount"

Calcified plaque is denser and generally more stable. Non-calcified plaque, especially low-attenuation plaque (sometimes called "lipid-rich" plaque), is softer and more likely to rupture. Mixed plaque contains both components.

The PROMISE trial (N=10,003) found that CCTA-detected non-calcified plaque predicted adverse cardiac events independently of stenosis severity. [2] That finding shifted clinical thinking: even a 30% stenosis with abundant non-calcified plaque may warrant more aggressive lipid lowering than a 55% calcified stenosis in an older adult.

Vessel Involvement: How Many Arteries Are Affected

Reports specify whether plaque is in one vessel (single-vessel disease), two vessels, or all three main arteries (three-vessel disease or left main disease). Left main stenosis above 50% is treated as a surgical-level emergency regardless of symptoms, because it threatens blood supply to the entire left ventricle.

Understanding the CAD-RADS 2.0 Grading System

CAD-RADS 2.0, published in 2022 by the Society of Cardiovascular Computed Tomography and the American College of Cardiology, replaced the original 2016 system and is now the standard reporting framework in the United States. [3] It assigns your scan one of six grades and adds modifier letters for plaque type and functional significance.

CAD-RADS 0 and 1: No Plaque or Minimal Plaque

CAD-RADS 0 means the radiologist saw zero coronary plaque. Your 10-year major adverse cardiovascular event (MACE) risk in this category is roughly 0.4%, based on data from the CORE320 registry. [4] CAD-RADS 1 means 1 to 24% stenosis with minimal plaque. Both grades typically require no additional cardiac testing beyond guideline-recommended prevention counseling.

CAD-RADS 2 and 3: Mild to Moderate Non-Obstructive Disease

CAD-RADS 2 (25 to 49% stenosis) and CAD-RADS 3 (50 to 69% stenosis, now reclassified as the boundary zone) represent non-obstructive or borderline obstructive disease. The 2022 update added the "V" modifier (for vulnerable/high-risk plaque features such as low-attenuation plaque, napkin-ring sign, positive remodeling, or spotty calcification) to flag patients who may need more aggressive therapy despite low stenosis grades. [3]

The ACC/AHA 2019 Primary Prevention Guideline recommends high-intensity statin therapy when the CAC score exceeds 100 Agatston units. [5] A similar principle applies here: CAD-RADS 2 with the V modifier often justifies starting or intensifying a statin even without obstructive stenosis.

CAD-RADS 4 and 5: Obstructive and Very High-Risk Disease

CAD-RADS 4 is split into 4A (70 to 99% stenosis in one vessel) and 4B (70 to 99% stenosis in two or more vessels, or left main 50 to 69%). These grades typically prompt functional stress testing or direct referral to invasive coronary angiography.

CAD-RADS 5 is total occlusion of at least one vessel. It demands urgent cardiology evaluation. Some patients with CAD-RADS 5 are asymptomatic because collateral vessels have developed, but the structural finding still requires a management plan.

The Coronary Artery Calcium Score: Your CCTA's Companion Number

Many CCTA reports include or reference a CAC score measured in Agatston units. The CAC score counts only calcified plaque, so it does not capture soft plaque. A CAC of zero is reassuring but not identical to a CCTA CAD-RADS 0, because non-calcified plaque can exist without any calcium.

The MESA study (N=6,814) demonstrated that a CAC score above 300 Agatston units placed adults in a risk category equivalent to established diabetes for predicting coronary heart disease events over 10 years. [6] The ACC/AHA Pooled Cohort Equation already estimates your baseline risk; the CAC score refines that estimate by imaging what is actually in the artery wall.

CAC Score Ranges at a Glance

| CAC score (Agatston units) | Risk category | |---|---| | 0 | Very low (not zero) | | 1 to 99 | Mild; statin discussion warranted | | 100 to 299 | Moderate; statin generally recommended | | 300 or above | High; high-intensity statin plus lifestyle | | 1,000 or above | Very high; cardiology referral appropriate |

What "High-Risk Plaque Features" Mean in Your Report

The V modifier in CAD-RADS 2.0 flags high-risk plaque features (HRPFs). Your radiologist may describe one or more of the following:

• Low-attenuation plaque (LAP): Appears dark on CT, indicating a large lipid core. The PROSPECT II study found LAP volume above 4 mm cubed predicted future heart attack at the lesion level with an odds ratio of 4.9. [7]
• Napkin-ring sign: A dark core surrounded by a bright rim on cross-sectional images. This pattern correlates with thin-cap fibroatheroma, the plaque subtype most prone to rupture.
• Positive remodeling: The artery wall bulges outward to accommodate plaque, hiding the stenosis degree while the plaque volume remains large.
• Spotty calcification: Small calcium deposits scattered through soft plaque, associated with active inflammation.

Finding even one HRPF changes the risk conversation. It does not automatically mean you will have a heart attack, but it does mean the plaque is less stable and may respond better to high-intensity statin therapy or PCSK9 inhibitor treatment.

How to Lower Your Risk After a Concerning CCTA Result

The following framework reflects HealthRX's clinical review of current ACC/AHA and ESC guidelines and is meant to guide conversations with your physician, not replace them.

A CCTA result does not change in response to a single treatment within weeks the way a cholesterol panel might. The goal is to stabilize and shrink plaque over months to years. Three evidence-based levers exist.

Statin Therapy: The First-Line Tool

High-intensity statins (rosuvastatin 20 to 40 mg or atorvastatin 40 to 80 mg daily) reduce LDL cholesterol by 50% or more and have been shown to reduce non-calcified plaque volume on serial CCTA. The SATURN trial (N=1,039) compared rosuvastatin 40 mg to atorvastatin 80 mg over 24 months and found both drugs significantly reduced total atheroma volume, with rosuvastatin producing a median reduction of 6.4% versus atorvastatin's 4.4%. [8]

Paradoxically, statin therapy increases the CAC score over time because it calcifies previously soft plaque. A rising CAC on serial scans while taking a statin is not always a sign of progression. It may reflect plaque stabilization.

PCSK9 Inhibitors for High-Risk Patients

If LDL remains above 70 mg/dL on maximum-tolerated statin therapy, guidelines support adding a PCSK9 inhibitor (evolocumab or alirocumab). The GLAGOV trial (N=968) showed that adding evolocumab to statin therapy reduced percent atheroma volume by 0.95% versus a 0.05% increase in the placebo group (P<0.001) at 76 weeks. [9]

Lifestyle Modifications With Documented Plaque Impact

The PREDIMED trial (N=7,447) showed that a Mediterranean diet reduced major cardiovascular events by approximately 30% compared to a low-fat control diet. [10] Specific targets:

• Aerobic exercise: 150 minutes per week of moderate intensity or 75 minutes of vigorous activity, per ACC/AHA physical activity guidelines
• LDL target: below 70 mg/dL for intermediate and high-risk patients; below 55 mg/dL for very high-risk patients (prior MI or CAD-RADS 4 to 5)
• Blood pressure: below 130/80 mmHg
• Smoking cessation: associated with a 36% relative risk reduction in coronary events within 5 years of quitting

Normal Coronary CT Angiogram Range: What "Normal" Looks Like

"Normal" on a CCTA means CAD-RADS 0: no identifiable plaque in any of the major coronary segments. The Society of Cardiovascular Computed Tomography defines normal as the complete absence of coronary artery plaque or stenosis. [3]

A report may also be labeled "non-diagnostic" if image quality was limited by arrhythmia, high heart rate, or patient motion. That is different from normal and usually requires repeat imaging or an alternative test.

Age and Sex Context for "Normal"

Age matters. A 45-year-old woman with CAD-RADS 0 has a genuinely reassuring result. A 45-year-old man with the same scan result is less statistically surprising, because women tend to develop coronary plaque roughly a decade later than men on average, based on epidemiological data from the Framingham Heart Study. [11] A "normal" CCTA in a 70-year-old man with diabetes and hypertension is unusual enough to warrant clinical discussion about scan quality and patient-specific risk factors.

When a CCTA Should Be Repeated

No major guideline specifies a standard repeat-imaging interval for CCTA. The 2021 ACC/AHA Chest Pain Guideline notes that repeat non-invasive testing within five years is generally not indicated in patients with a CAD-RADS 0 or 1 result who remain asymptomatic. [1] For CAD-RADS 2 to 3, a physician might reassess imaging in 3 to 5 years depending on symptom change and risk-factor control.

Reading the Actual Report: A Section-by-Section Guide

Your CCTA report will likely arrive as a PDF from the radiologist. Here is what each section means.

Clinical Indication and Technique

This section states why the scan was ordered and what scanner and protocol were used. A 256-slice or dual-source scanner with a dose-modulation protocol keeps radiation below 3 mSv for most patients. If you see the phrase "retrospective gating" rather than "prospective gating," your scan likely used a slightly higher radiation dose, though still well within safe limits for a one-time study.

Coronary Anatomy and Dominance

Most people are "right dominant," meaning the right coronary artery supplies the posterior wall of the heart. About 10% are "left dominant" and 10% are "co-dominant." Dominance does not directly affect risk but influences how a cardiologist interprets which vessels are most critical.

Segment-by-Segment Findings

This is the heart of the report. The radiologist grades each named segment: left main, proximal/mid/distal left anterior descending (LAD), diagonal branches, left circumflex (LCx), obtuse marginals, and the right coronary artery (RCA) with its branches. A finding of "mild non-calcified plaque, proximal LAD, estimated stenosis 20 to 30%" is a typical CAD-RADS 2 entry.

Impression and CAD-RADS Grade

The final paragraph synthesizes everything. The CAD-RADS grade appears here along with any modifiers: N (non-diagnostic segment), V (high-risk plaque), I (ischemia by CT-FFR), S (stenosis requiring further evaluation), and G (graft assessment for post-CABG patients).

The ACC/AHA guideline states: "CCTA provides high diagnostic accuracy for obstructive CAD and excellent prognostic data to guide therapeutic decisions." [1] That sentence reflects the clinical weight your cardiologist or primary care physician should give this report.

When Results Are Indeterminate or Discordant

A CCTA can be technically non-diagnostic in patients with very high heart rates during the scan, irregular rhythms (atrial fibrillation), or heavy coronary calcification that creates blooming artifact. A CAC score above 1,000 Agatston units frequently limits CCTA accuracy because dense calcium obscures the lumen.

In those cases, the next step is usually a functional test: nuclear stress myocardial perfusion imaging (MPI) or stress cardiac MRI. The 2021 ACC/AHA guideline lists CCTA and functional imaging as equivalent Class I options for stable chest pain evaluation; the choice depends on local expertise and the specific clinical question. [1]

Questions to Ask Your Physician After Receiving Your CCTA Report

Bring these five questions to your follow-up visit:

1. What is my overall CAD-RADS grade, and does my report include the V modifier for high-risk plaque?
2. Does my LDL need to be lower, and should I be on a statin or a higher-dose statin?
3. Are any of my coronary segments non-diagnostic, and do I need a follow-up test?
4. What blood pressure target applies to me given these findings?
5. At what point would you recommend repeating imaging or proceeding to invasive angiography?

A CCTA result is not a verdict. Patients with CAD-RADS 3 who aggressively control LDL (to below 55 mg/dL), blood pressure, and lifestyle factors can achieve measurable plaque regression over 24 months, as the SATURN data showed. Start with your statin dose.